| B - Blood and Blood Forming Organs | | |
|
| B03 - Antianemic Preparations | | |
|
| B03X - Other Antianemic Preparations | This group comprises antianemic preparations other than iron, vitamin B12 and folic acid.
Glutamine for treatment of sickle cell disease is classified in A16AA03.
Cell- and gene- therapy products used for the treatment of Fanconi anemia and sickle cell disease are classified in B06AX.
|
|
| B03XA - Other Antianemic Preparations | | | The DDDs are based on the treatment of renal anemia in patients maintained by dialysis.
The DDD for luspatercept is based on the starting dose in the treatment of myelodydplastic syndromes and beta-thalassaemia.
|
|
| B03XA03 - Methoxy Polyethylene Glycol-Epoetin Beta | |
|
